|

Indicators Affecting PVT Recanalization

RECRUITINGSponsored by Shanghai Zhongshan Hospital
Actively Recruiting
SponsorShanghai Zhongshan Hospital
Started2017-01-01
Est. completion2027-12-31
Eligibility
Age18 Years – 80 Years
View on ClinicalTrials.gov →

NCT07473375

Summary

This is a retrospective-prospective study conducted at Zhongshan Hospital, Fudan University, to explore portal vein thrombosis (PVT) in patients with cirrhosis and gastroesophageal varices (GEV). It aimed to provide insights into the diagnosis, follow-up, and factors influencing PVT recanalization, to help patients, families, and healthcare providers understand the disease and related clinical management.

Eligibility

Age: 18 Years – 80 Years
Inclusion Criteria:

* diagnosed as cirrhosis and confirmed gastroesophageal varices by endoscopy;

  * all patients were diagnosed as PVT by CTA at admission.

Exclusion Criteria:

* patients with hepatocellular carcinoma;

  * patients with extrahepatic malignancies;

    * history of liver transplantation or TIPS;

      * lack of information regarding anticoagulation therapy；

        * those with cavernous transformation of the portal vein(CTPV) .

Conditions5

CirrhosisLiver DiseasePortal Hypertension Related to CirrhosisPortal Hypertension, NoncirrhoticPortal Vein Thrombosis

Browse More Trials

Liver Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.